tiprankstipranks
Trending News
More News >
CSL (CMXHF)
OTHER OTC:CMXHF

Compare CSL (CMXHF) vs. Competitors

Compare
77 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
$121.34
$60.27B
19.35
-26.39%
8 Buy
3 Hold
0 Sell
Moderate Buy
Clinuvel Pharmaceuticals
AU$11.08
AU$611.44M
16.86
4.19%
1 Buy
0 Hold
0 Sell
Moderate Buy
Mesoblast Limited
AU$2.68
AU$3.46B
-20.52
-3.25%
3 Buy
0 Hold
0 Sell
Strong Buy
Neuren Pharmaceuticals Limited
AU$17.65
AU$2.24B
15.12
21.31%
5 Buy
0 Hold
0 Sell
Strong Buy
Immutep Ltd
AU$0.26
AU$677.91M
-10.90
39.39%
3 Buy
0 Hold
0 Sell
Strong Buy
Telix Pharmaceuticals
AU$10.95
AU$3.71B
219.88
-59.28%
6 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CMXHF
CSL
121.34
-46.06
-27.51%
AU:CUV
Clinuvel Pharmaceuticals
12.18
0.35
2.94%
AU:MSB
Mesoblast Limited
2.68
-0.19
-6.62%
AU:NEU
Neuren Pharmaceuticals Limited
17.65
2.92
19.82%
AU:IMM
Immutep Ltd
0.46
0.13
39.39%
AU:TLX
Telix Pharmaceuticals
10.95
-17.35
-61.31%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts